In the wake of US funding cuts for global aid, numerous donor-funded health facilities in South Africa have shut down and ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

STRUGGLING to provide basics at public hospitals, government has sensationally claimed it had already decided to 'takeover' the health sector before American President Donald Trump's unexpected ...

The rollback of funding for anti-malaria efforts in the Mekong is just one of many examples of cuts that are raising alarm ...

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...